Filtered By:
Cancer: Lymphoma
This page shows you your search results in order of date. This is page number 6.
Order by Relevance | Date
Total 25370 results found since Jan 2013.
Angioimmunoblastic T-cell Lymphoma Mimicking Systemic Lupus Erythematosus: A Case Report and Literature Review
CONCLUSION: Patients with AITL generally have a poor prognosis. Rarely do reported cases show AITL mimicking SLE. AITL should be considered during clinical practice to prevent missed diagnoses or misdiagnoses.PMID:37708543
Source: Alternative Therapies in Health and Medicine - September 14, 2023 Category: Complementary Medicine Authors: Yanni Wang Zhenglun Pan Source Type: research
Non-hodgkin's lymphoma masquerading as a right atrial mass
Ann Card Anaesth. 2023 Apr-Jun;26(2):209-210. doi: 10.4103/aca.aca_119_22.NO ABSTRACTPMID:37706389 | PMC:PMC10284470 | DOI:10.4103/aca.aca_119_22
Source: Annals of Cardiac Anaesthesia - September 14, 2023 Category: Anesthesiology Authors: Prateek Arora Omer M Mujahid Subrata K Singha Source Type: research
A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma
Haematologica. 2023 Sep 14. doi: 10.3324/haematol.2022.282246. Online ahead of print.ABSTRACTNot available.PMID:37706336 | DOI:10.3324/haematol.2022.282246
Source: Haematologica - September 14, 2023 Category: Hematology Authors: Todd A Fehniger Marcus P Watkins Nkiruka Ezenwajiaku Fei Wan David D Hurd Amanda F Cashen Kristie A Blum Andre Goy Timothy S Fenske Nina D Wagner-Johnston Kenneth Carson Marilyn J Siegel David Russler-Germain Stephanie E Schneider Neha Mehta-Shah Brad Kah Source Type: research
Diffuse large B-cell lymphoma involving the central nervous system: biologic rationale for targeted therapy
Haematologica. 2023 Sep 14. doi: 10.3324/haematol.2021.278613. Online ahead of print.ABSTRACTDiffuse large B-cell lymphoma (DLBCL) is an aggressive B-cell lymphoma curable even in advanced stages. DLBCL involving the central nervous system (CNS) is more difficult to cure and fewer treatment options exist. Primary CNS lymphoma (PCNSL) refers to aggressive lymphomas confined to the CNS, and are almost always DLBCL. Standard approaches for PCNSL use high-dose methotrexate based combinations as induction therapy and younger patients often receive dose-intensive consolidation. However, dose-intensive therapies are not suitable ...
Source: Haematologica - September 14, 2023 Category: Hematology Authors: Mark Roschewski Daniel J Hodson Source Type: research
A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma
Haematologica. 2023 Sep 14. doi: 10.3324/haematol.2022.282246. Online ahead of print.ABSTRACTNot available.PMID:37706336 | DOI:10.3324/haematol.2022.282246
Source: Haematologica - September 14, 2023 Category: Hematology Authors: Todd A Fehniger Marcus P Watkins Nkiruka Ezenwajiaku Fei Wan David D Hurd Amanda F Cashen Kristie A Blum Andre Goy Timothy S Fenske Nina D Wagner-Johnston Kenneth Carson Marilyn J Siegel David Russler-Germain Stephanie E Schneider Neha Mehta-Shah Brad Kah Source Type: research
Diffuse large B-cell lymphoma involving the central nervous system: biologic rationale for targeted therapy
Haematologica. 2023 Sep 14. doi: 10.3324/haematol.2021.278613. Online ahead of print.ABSTRACTDiffuse large B-cell lymphoma (DLBCL) is an aggressive B-cell lymphoma curable even in advanced stages. DLBCL involving the central nervous system (CNS) is more difficult to cure and fewer treatment options exist. Primary CNS lymphoma (PCNSL) refers to aggressive lymphomas confined to the CNS, and are almost always DLBCL. Standard approaches for PCNSL use high-dose methotrexate based combinations as induction therapy and younger patients often receive dose-intensive consolidation. However, dose-intensive therapies are not suitable ...
Source: Haematologica - September 14, 2023 Category: Hematology Authors: Mark Roschewski Daniel J Hodson Source Type: research
Non-hodgkin's lymphoma masquerading as a right atrial mass
Ann Card Anaesth. 2023 Apr-Jun;26(2):209-210. doi: 10.4103/aca.aca_119_22.NO ABSTRACTPMID:37706389 | PMC:PMC10284470 | DOI:10.4103/aca.aca_119_22
Source: Annals of Cardiac Anaesthesia - September 14, 2023 Category: Anesthesiology Authors: Prateek Arora Omer M Mujahid Subrata K Singha Source Type: research
Angioimmunoblastic T-cell Lymphoma Mimicking Systemic Lupus Erythematosus: A Case Report and Literature Review
CONCLUSION: Patients with AITL generally have a poor prognosis. Rarely do reported cases show AITL mimicking SLE. AITL should be considered during clinical practice to prevent missed diagnoses or misdiagnoses.PMID:37708543
Source: Alternative Therapies in Health and Medicine - September 14, 2023 Category: Complementary Medicine Authors: Yanni Wang Zhenglun Pan Source Type: research
Non-hodgkin's lymphoma masquerading as a right atrial mass
Ann Card Anaesth. 2023 Apr-Jun;26(2):209-210. doi: 10.4103/aca.aca_119_22.NO ABSTRACTPMID:37706389 | PMC:PMC10284470 | DOI:10.4103/aca.aca_119_22
Source: Annals of Cardiac Anaesthesia - September 14, 2023 Category: Anesthesiology Authors: Prateek Arora Omer M Mujahid Subrata K Singha Source Type: research
Bortezomib and Vorinostat Therapy as Maintenance Therapy Post Autologous Transplant for Non-Hodgkin's Lymphoma Using R-BEAM or BEAM Transplant Conditioning Regimen
CONCLUSIONS: BV can be given post-ASCT for NHL and produces excellent disease-free and overall survival rates.PMID:37708877 | DOI:10.1159/000533944
Source: Acta Haematologica - September 14, 2023 Category: Hematology Authors: Leona A Holmberg David G Maloney Laura Connelly-Smith Source Type: research
A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma
Haematologica. 2023 Sep 14. doi: 10.3324/haematol.2022.282246. Online ahead of print.ABSTRACTNot available.PMID:37706336 | DOI:10.3324/haematol.2022.282246
Source: Haematologica - September 14, 2023 Category: Hematology Authors: Todd A Fehniger Marcus P Watkins Nkiruka Ezenwajiaku Fei Wan David D Hurd Amanda F Cashen Kristie A Blum Andre Goy Timothy S Fenske Nina D Wagner-Johnston Kenneth Carson Marilyn J Siegel David Russler-Germain Stephanie E Schneider Neha Mehta-Shah Brad Kah Source Type: research
Diffuse large B-cell lymphoma involving the central nervous system: biologic rationale for targeted therapy
Haematologica. 2023 Sep 14. doi: 10.3324/haematol.2021.278613. Online ahead of print.ABSTRACTDiffuse large B-cell lymphoma (DLBCL) is an aggressive B-cell lymphoma curable even in advanced stages. DLBCL involving the central nervous system (CNS) is more difficult to cure and fewer treatment options exist. Primary CNS lymphoma (PCNSL) refers to aggressive lymphomas confined to the CNS, and are almost always DLBCL. Standard approaches for PCNSL use high-dose methotrexate based combinations as induction therapy and younger patients often receive dose-intensive consolidation. However, dose-intensive therapies are not suitable ...
Source: Haematologica - September 14, 2023 Category: Hematology Authors: Mark Roschewski Daniel J Hodson Source Type: research
